Recent CNIC News

New report shines spotlight on Canadian isotope excellence

Medical isotope ecosystem directory details tremendous capabilities of Canada’s isotope industry.   Today, the Organization of Canadian Nuclear Industries (OCNI) and the Canadian Nuclear Isotope Council (CNIC) released the Canadian Medical Isotope Ecosystem Directory. The directory demonstrates the capabilities of the Canadian isotope sector companies and their leading international expertise as well as highlights the […]   READ MORE

Canada is an Isotope Superpower

On the CNIC’s 3rd birthday we highlight why the isotope sector is key contributor to economic recovery. The importance of nuclear medicine and medical isotopes in our daily lives — and Canada’s global leadership position in this sector — admittedly flies under the radar for most people, and their significance has never been more vital […]   READ MORE

Storied Canadian manufacturer, Advanced Cyclotron Systems, joins the CNIC

TORONTO – March 31, 2021 – Advanced Cyclotron Systems Inc. (ACSI), a world leader in the design and manufacturing of cyclotron equipment, including PET and SPECT radioisotope production cyclotrons, will join the Canadian Nuclear Isotope Council (CNIC), further cementing the industry association as the pre-eminent representative of the Canadian Isotope sector. “Over the past two-and-half […]   READ MORE

CNIC and Bangor University partner to export Canadian isotope sector expertise following digital trade mission

TORONTO – March 30, 2021 – Following a market study completed in March 2020, the Welsh government worked with the Organization of Canadian Nuclear Industries, the Canadian Nuclear Association, and Natural Resources Canada on a digital trade mission. The four-day event explored bilateral opportunities in Canada, the UK, and other markets of interest for Welsh […]   READ MORE

CPDC Announces First Patient Dosed in a Phase 3 Clinical Trial of a Prostate Cancer Diagnostic Imaging Product, [18F]PSMA-1007

Hamilton, Ontario, February 24, 2021 – The Centre for Probe Development and Commercialization (CPDC), a global leader in the development, production and commercialization of radiopharmaceuticals, is announcing today that the first patient has been dosed and imaged in a Phase 3 trial for [18F]PSMA-1007. This diagnostic imaging product is a positron-emitting tomography (PET) agent that […]   READ MORE


Canada has a unique position that is recognized globally: it is the world’s largest supplier of Cobalt-60 and Iodine-125; it hosts mostly all supply chain partners within its borders; it has a long tradition in supply chain collaboration; and it is renowned around the world for developing new applications.

Isotopes: Global Importance and Opportunities for Canada

This publication highlights the important of having a continuous and reliable supply of medical isotopes accessible to the rest of the world.

Introduction to CNIC

A glance at this independent organization and its role to advocate for Canada’s role in the production of the world’s supply of isotopes.

Did You Know?

The Canadian Nuclear Safety Commission licenses the use and production of over 250 radioisotopes in Canada. And more key facts. . . .

Policy Magazine Isotope Article

Canada’s opportunity to lead in the fight against cancer and disease around the world with some of the rarest drugs on earth.

Brain Tumor Awareness Month: Gamma Knife
Canadian Nuclear Isotope Council Turns Two
How Canadian Isotopes Are Playing A Role In Fighting COVID-19
CNIC Writes to all Newly Elected MP’s about the importance of isotopes
CNIC Member Spotlight: McMaster University
CNIC Member Spotlight: TRIUMF